Prediction of early recurrence after acute ischemic stroke

JAMA Neurology

Volumn 73, Issue 4, 2016, Pages 396-401

  Arsava, E Murat ^a   Kim, Gyeong Moon ^b   Oliveira Filho, Jamary ^c   Gungor, Levent ^d   Noh, Hyun Jin ^b   De Jesus Lordelo, Morgana ^c   Avery, Ross ^e   Maier, Ilko L ^f   Ay, Hakan ^e  

^a HACETTEPE UNIVERSITY   (Turkey)

^b Samsung Medical Center   (South Korea)

^c FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^d ONDOKUZ MAYIS UNIVERSITY   (Turkey)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN INFARCTION; BRAIN ISCHEMIA; BRAZIL; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; RECURRENT DISEASE; SOUTH KOREA; UNITED STATES; PREDICTIVE VALUE; RISK FACTOR; STROKE;

BRAIN ISCHEMIA; COHORT STUDIES; HUMANS; PREDICTIVE VALUE OF TESTS; RECURRENCE; RISK FACTORS; STROKE; UNITED STATES;

EID: 84963795926     PISSN: 21686149     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaneurol.2015.4949     Document Type: Article

References (21)

1. Ay H, Gungor L, Arsava EM, et al. A score to predict early risk of recurrence after ischemic stroke. Neurology. 2010;74(2):128-135.
2. Ay H, Benner T, Arsava EM, et al. A computerized algorithm for etiologic classification of ischemic stroke: the Causative Classification of Stroke System. Stroke. 2007;38(11):2979-2984.
3. Hosmer DW Jr, Lemeshow S, Sturdivant RX. Assessing the fit of the model. In: Hosmer DW Jr, Lemeshow S, Sturdivant RX, eds. Applied Logistic Regression. 3rd ed. Hoboken, NJ: John Wiley & Sons, Inc; 2013:153-226.
4. Arsava EM, Furie KL, Schwamm LH, Sorensen AG, Ay H. Prediction of early stroke risk in transient symptoms with infarction: relevance to the new tissue-based definition. Stroke. 2011;42(8):2186-2190.
5. Marnane M, Ni Chroinin D, Callaly E, et al. Stroke recurrence within the time window recommended for carotid endarterectomy. Neurology. 2011;77(8):738-743.
6. Grau AJ, Weimar C, Buggle F, et al. Risk factors, outcome, and treatment in subtypes of ischemic stroke: the German stroke data bank. Stroke. 2001;32(11):2559-2566.
7. Saxena R, Lewis S, Berge E, Sandercock PA, Koudstaal PJ. Risk of early death and recurrent stroke and effect of heparin in 3169 patients with acute ischemic stroke and atrial fibrillation in the International Stroke Trial. Stroke. 2001;32(10):2333-2337.
8. Wang Y, Xu J, Zhao X, et al. Association of hypertension with stroke recurrence depends on ischemic stroke subtype. Stroke. 2013;44(5):1232-1237.
9. TOAST Investigators. Low molecular weight heparinoid ORG 10172 (Danaparoid), and outcome after ischemic stroke. JAMA. 1998;279(16):1265-1272.
10. Hankey GJ, Jamrozik K, Broadhurst RJ, et al. Long-term risk of first recurrent stroke in the Perth Community Stroke Study. Stroke. 1998;29(12):2491-2500.
11. Hardie K, Hankey GJ, Jamrozik K, Broadhurst RJ, Anderson C. Ten-year risk of first recurrent stroke and disability after first-ever stroke in the Perth Community Stroke Study. Stroke. 2004;35(3):731-735.
12. Jørgensen HS, Nakayama H, Reith J, Raaschou HO, Olsen TS. Stroke recurrence: predictors, severity, and prognosis: The Copenhagen Stroke Study. Neurology. 1997;48(4):891-895.
13. Kernan WN, Viscoli CM, Brass LM, et al. The Stroke Prognosis Instrument II (SPI-II): a clinical prediction instrument for patients with transient ischemia and nondisabling ischemic stroke. Stroke. 2000;31(2):456-462.
14. Weimar C, Diener HC, Alberts MJ, et al; REduction of Atherothrombosis for Continued Health Registry Investigators. The Essen stroke risk score predicts recurrent cardiovascular events: a validation within the REduction of Atherothrombosis for Continued Health (REACH) registry. Stroke. 2009;40(2):350-354.
15. Moroney JT, Bagiella E, Paik MC, Sacco RL, Desmond DW. Risk factors for early recurrence after ischemic stroke: the role of stroke syndrome and subtype. Stroke. 1998;29(10):2118-2124.
16. Sacco RL, Foulkes MA, Mohr JP, Wolf PA, Hier DB, Price TR; The Stroke Data Bank. Determinants of early recurrence of cerebral infarction. Stroke. 1989;20(8):983-989.
17. Petty GW, Brown RD Jr, Whisnant JP, Sicks JD, O'Fallon WM, Wiebers DO. Ischemic stroke subtypes: a population-based study of functional outcome, survival, and recurrence. Stroke. 2000;31(5):1062-1068.
18. D'Agostino RB Sr, Vasan RS, Pencina MJ, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008;117(6):743-753.
19. Steyerberg EW. Patterns of external validity. In: Steyenberg EW, ed. Clinical Prediction Models. New York, NY: Springer Science + Business Media LLC; 2009:335-359.
20. Maier IL, Bauerle M, Kermer P, Helms HJ, Buettner T. Risk prediction of very early recurrence, death and progression after acute ischaemic stroke. Eur J Neurol. 2013;20(4):599-604.
21. Vergouwe Y, Steyerberg EW, Eijkemans MJ, Habbema JD. Substantial effective sample sizes were required for external validation studies of predictive logistic regression models. J Clin Epidemiol. 2005;58(5):475-483.